RT increases the release of chemokines (CXCL16, a chemokine that binds to CXCR6 on Th1 CD4 and effector CD8 T cells) by mouse breast cancer (4T1) cells, therefore enhances the infiltration of cytotoxic T cells (104). This evidence concerns the gene CD8A and breast carcinoma.